TNF-α variants
US7056695B2 · kind B2 · utility
35Cited by
22References
13Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 2, 2001 |
| Grant date | Jun 6, 2006 |
| Priority date | — |
| Expiry date | Mar 2, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K38/191
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to novel proteins with TNF-α antagonist activity and nucleic acids encoding these proteins. The invention further relates to the use of the novel proteins in the treatment of TNF-α related disorders, such as rheumatoid arthritis.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.